YraP contributes to cell envelope integrity and virulence of Salmonella enterica serovar Typhimurium

Faye C. Morris, Timothy J. Wells, Jack A. Bryant, Anna E. Schager, Yanina R. Sevastsyanovich, Derrick J.P. Squire, Jennifer Marshall, Georgia L. Isom, Jessica Rooke, Riyaz Maderbocus, Timothy J. Knowles, Michael Overduin, Amanda E. Rossiter, Adam F. Cunningham, Ian R. Henderson

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Mutations in E -regulated lipoproteins have previously been shown to impact bacterial viability under conditions of stress and during in vivo infection. YraP is conserved across a number of Gram-negative pathogens, including Neisseria meningitidis, where the homolog is a component of the Bexsero meningococcal group B vaccine. Investigations using laboratory-adapted Escherichia coli K-12 have shown that yraP mutants have elevated sensitivity to a range of compounds, including detergents and normally ineffective antibiotics. In this study, we investigate the role of the outer membrane lipoprotein YraP in the pathogenesis of Salmonella enterica serovar Typhimurium. We show that mutations in S. Typhimurium yraP result in a defective outer membrane barrier with elevated sensitivity to a range of compounds. This defect is associated with attenuated virulence in an oral infection model and during the early stages of systemic infection. We show that this attenuation is not a result of defects in lipopolysaccharide and O-antigen synthesis, changes in outer membrane protein levels, or the ability to adhere to and invade eukaryotic cell lines in vitro.

Original languageEnglish
Article numbere00829-17
Number of pages12
JournalInfection and Immunity
Volume86
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Salmonella
  • Virulence
  • YraP

Cite this